Transcatheter Mitral Valve Implantation (TMVI)

The FORTIS transcatheter mitral valve (Edwards Lifesciences, Irvine, CA, USA) is a self-expanding device implanted via a transapical approach that is currently undergoing first-in-man trials. Below is a link to the paper with the latest evidence on the device and a link to the news release.

Bapat et al. 2014 Eurointervention

Edwards News Release

X0000_Edwards_Fortis transcatheter Mitral valve copy_0

About The Author

SHDA is supported by

Recent Tweets

Subscribe

Upcoming Meetings

january

21janAll Day25American Society of Echocardiography (ASE) Echo Hawaii

27janAll Day29Society of Thoracic Surgeons (STS) 55th Annual MeetingSTS 2018

X